Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.97 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.77 |
| ▸ | HTT | P42858 | 3/20 | 0.77 |
| ▸ | LMNA | P02545 | 2/20 | 0.77 |
| ▸ | TSHR | P16473 | 1/20 | 0.77 |
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | IL1RN | P18510 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.72 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | CNR1 | P21554 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14507610 | 0.98 | GAA (1.00) | GAASMN1; SMN2HTTLMNATSHR | |
| SCHEMBL2856801 | 0.88 | GAA (0.76) | GAASMN1; SMN2HTTLMNATSHR | |
| SCHEMBL2852725 | 0.87 | GAA (0.74) | GAASMN1; SMN2HTTLMNATSHR | |
| SCHEMBL2850336 | 0.87 | GAA (0.74) | GAALMNATSHRALDH1A1AKR1C3 | |
| SCHEMBL2851156 | 0.87 | GAA (0.74) | GAASMN1; SMN2HTTLMNATSHR | |
| SCHEMBL1001486 | 0.86 | MAPT (1.00) | GAASMN1; SMN2HTTLMNATSHR | |
| SCHEMBL29463849 | 0.86 | MAPT (1.00) | GAASMN1; SMN2HTTLMNATSHR | |
| SCHEMBL17479344 | 0.85 | GAA (0.76) | GAASMN1; SMN2HTTLMNATSHR | |
| SCHEMBL1001537 | 0.84 | MAPT (0.97) | GAASMN1; SMN2HTTLMNATSHR | |
| SCHEMBL30213397 | 0.84 | MAPT (0.97) | GAASMN1; SMN2HTTLMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3749646-B1 | HETEROARYL COMPOUNDS AS KINASE INHIBITOR | FUJIAN HAIXI PHARMACEUTICALS CO LTD (CN) | 2022-04-06 | — | — | EP | claimed |
| EP-1761541-B1 | PYRRAZOLO-PYRIMIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2008-01-09 | — | — | EP | claimed |
| EP-1761541-A1 | PYRRAZOLO-PYRIMIDINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2007-03-14 | — | — | EP | claimed |
| WO-2005123738-A1 | PYRRAZOLO-PYRIMIDINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2005-12-29 | — | — | WO | claimed |
| EP-1761541-B1 | PYRRAZOLO-PYRIMIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2008-01-09 | — | — | EP | disclosed |
| EP-1761541-A1 | PYRRAZOLO-PYRIMIDINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2007-03-14 | — | — | EP | disclosed |
| WO-2005123738-A1 | PYRRAZOLO-PYRIMIDINE DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 2005-12-29 | — | — | WO | disclosed |